FDA Archives - Onco'Zine

Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Peter Hofland, Ph.D - June 24, 2020

Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith - December 20, 2019

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

FDA Approves New Drug for Advanced Bladder Cancer

Peter Hofland, Ph.D - December 19, 2019

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

Peter Hofland, Ph.D - September 16, 2019

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

Peter Hofland, Ph.D - July 24, 2019

United States and Europe Reach Milestone Agreement on Mutual Recognition of...

Danielle Garcia - July 20, 2019

FDA Approves Venetoclax as a Chemotherapy-Free Combination in Previously Untreated CLL

Peter Hofland, Ph.D - May 15, 2019

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal - March 5, 2019

Cancer Research Organizations Recommend Changes to Reduce Barriers to Clinical Trial...

Peter Hofland, Ph.D - August 10, 2018

Why Do We Need a Right-to-Try Bill in America?

Jane Orient - June 12, 2018

12 Page 1 of 2

LATEST NEWS

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Danielle Garcia - June 16, 2020

Press Releases | Cancer

PolyU discovers the effect of chemical compound PTU on autophagy in... July 9, 2020
The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with...(PRWeb July 09, 2020)Read the full story at https://www.prweb.com/releases/polyu_discovers_the_effect_of_chemical_compound_ptu_on_autophagy_in_zebrafish_embryos_sheds_light_on_cancer_medication_research/prweb17247058.htm
FrontStream and MoveSpring Join Forces to Power the American Cancer... July 8, 2020
Through best-in-class wellness and fundraising solutions, FrontStream and MoveSpring enable some of the largest companies in North America to drive employee engagement and raise more funds for the...(PRWeb July 08, 2020)Read the full story at https://www.prweb.com/releases/frontstream_and_movespring_join_forces_to_power_the_american_cancer_societys_corporate_virtual_fitness_fundraising_event_the_fit2be_cancer_free_challenge/prweb17242681.htm
National Breast Cancer Foundation Gaming Fundraising Event 'Game... July 8, 2020
Tripleclix Brought in to Elevate Game Pink’s Gaming Experience to Raise Awareness and Increase Fundraising(PRWeb July 08, 2020)Read the full story at https://www.prweb.com/releases/national_breast_cancer_foundation_gaming_fundraising_event_game_pink_returns_for_2020_in_an_all_digital_experience/prweb17242581.htm
Lymphoma Research Foundation Scientific Advisory Board Gains New... July 8, 2020
Elite Panel Expands Impact with Election of Leading Experts in Blood Cancer Research(PRWeb July 08, 2020)Read the full story at https://www.prweb.com/releases/lymphoma_research_foundation_scientific_advisory_board_gains_new_international_leaders_in_lymphoma/prweb17241448.htm
Childhood Cancer Foundation Names Tricia Martin To Its Board of... July 7, 2020
Bridge To A Cure Foundation announced Tricia Martin, RLA, LEED AP, as the latest addition to its Board of Directors.(PRWeb July 07, 2020)Read the full story at https://www.prweb.com/releases/childhood_cancer_foundation_names_tricia_martin_to_its_board_of_directors/prweb17229857.htm
Reaction from Cory Watson Attorneys: $10 Billion Settlement Reached in... July 1, 2020
Bayer, the maker of weed killer Roundup, will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its product causes cancer. Monsanto lost its first three Roundup trials...(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/reaction_from_cory_watson_attorneys_10_billion_settlement_reached_in_roundup_weed_killer_cancer_litigation/prweb17229746.htm
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches... July 1, 2020
Internal research programs to focus on building combination immunotherapies for brain cancer(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/silicon_beach_based_nonprofit_startup_cure_glioblastoma_launches_laboratory_operations_and_appoints_drs_john_boockvar_and_lisa_haile_as_senior_fellows/prweb17226957.htm
Lumeda Announces Formation of its Scientific Advisory Board July 1, 2020
Prominent medical and scientific experts to help company advance development of PDT products.(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/lumeda_announces_formation_of_its_scientific_advisory_board/prweb17222019.htm
Latest Data on IO Combinations Will Be Announced at the IO... June 30, 2020
IO Combinations 360°, organized by the Conference Forum, a combination-specific program, reports on the latest data and advancements to expedite more accurate therapies for patients faster taking...(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/latest_data_on_io_combinations_will_be_announced_at_the_io_combinations_360_conference_october_1_2_2020/prweb17225687.htm
Flagship Biosciences Launches New Clinical Diagnostics Service June 30, 2020
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient Care(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/flagship_biosciences_launches_new_clinical_diagnostics_service/prweb17223687.htm
Dimensional Insight Announces Registration Sponsorship of St. Jude... June 29, 2020
Event benefits kids with childhood cancer, other life-threatening diseases at St. Jude Children’s Research Hospital(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/dimensional_insight_announces_registration_sponsorship_of_st_jude_walk_run_boston/prweb17222315.htm
iRECIST Criteria: An Operational Approach in Oncology Clinical Trials,... June 29, 2020
In this free webinar, the featured speakers will discuss concepts of establishing iUPD and iCPD by category and data scenarios across imaging time point visits. Attendees will learn about image case...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/irecist_criteria_an_operational_approach_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17222231.htm
The Lymphoma Research Foundation Hosts Inaugural Swirl: America, An At... June 29, 2020
LRF Spokesperson and Acclaimed Journalist Lisa Guerrero Kicks Off Nationwide Cheeseboard Challenge to Drive Lymphoma Awareness(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/the_lymphoma_research_foundation_hosts_inaugural_swirl_america_an_at_home_tasting_virtual_fundraiser/prweb17222149.htm
AltruBio Inc. presented AbGn-107 Phase 1a chemo-refractory GI cancer... June 29, 2020
AltruBio Inc. http://www.altrubio.com, a clinical stage biotech company, has announced the presentation of AbGn-107 at the 2020 ASCO GI Cancer...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/altrubio_inc_presented_abgn_107_phase_1a_chemo_refractory_gi_cancer_results_at_asco_gi_2020/prweb17222550.htm

Tag: FDA

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

FDA Approves New Drug for Advanced Bladder Cancer

Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial...

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

United States and Europe Reach Milestone Agreement on Mutual Recognition of...

FDA Approves Venetoclax as a Chemotherapy-Free Combination in Previously Untreated CLL

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Cancer Research Organizations Recommend Changes to Reduce Barriers to Clinical Trial...

Why Do We Need a Right-to-Try Bill in America?

LATEST NEWS

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

AACR 2020: Positive Preclinical Safety and Efficacy Data for TXR-311 in HCC

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...